Pricing Log in Create free account

ICON PLC (ICLR) vs Illumina, Inc. (ILMN)

ICON PLC and Illumina, Inc. are both Diagnostics & Research companies. Illumina, Inc. is the larger, with a market value of $31.5B against $15.1B — 2.1× the size. ICON PLC trades at the lower P/E: 34.5× against 35.6×. Illumina, Inc. grew revenue faster over the last twelve months: 5.83% against 1.82%. Illumina, Inc. has the higher net margin (19.7% vs 5.45%) and the higher return on invested capital (16.7% vs 3.84%). Across the 22 metrics below, Illumina, Inc. leads on 12 and ICON PLC on 10.

Valuation

Metric ICLR ILMN Diagnostics & Research median
P/E 34.48 35.62 34.52
P/S 1.88 6.98 4.24
P/B 1.70 10.07 3.42
Price to free cash flow 18.10 30.41 33.51
EV/EBITDA 17.86 26.35 23.44
EV/Sales 2.35 7.19 5.18
Earnings yield 2.90% 2.81% (1.50%)
Free cash flow yield 5.53% 3.29% 0.00%

Profitability

Metric ICLR ILMN Diagnostics & Research median
Gross margin 23.43% 67.87% 48.32%
Operating margin 8.72% 21.18% (5.68%)
Net margin 5.45% 19.72% (4.10%)
Free cash flow margin 10.41% 23.29% 0.00%
Return on equity 4.86% 32.39% 0.00%
Return on assets 2.74% 13.78% (6.05%)
Return on invested capital 3.84% 16.70% 0.00%

Growth

Metric ICLR ILMN Diagnostics & Research median
Revenue growth (TTM) 1.82% 5.83% 8.99%
EPS growth (last fiscal year) (67.42%) 170.87% 20.36%
Revenue growth, 5-year CAGR 24.15% 6.04% 7.30%
Net income growth, 5-year CAGR (7.15%) 5.32% 0.00%

Health

Metric ICLR ILMN Diagnostics & Research median
Debt to equity 0.37 0.57 0.01
Current ratio 1.32 2.63 2.27
Net debt to EBITDA 3.34 (0.13) 0.68

Dividend

Metric ICLR ILMN Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric ICLR ILMN Diagnostics & Research median
Market cap 15.11b 31.45b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack